Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Capabilities of perfusion ASPECTS in predicting the efficiency of intravenous thrombolytic therapy

https://doi.org/10.14412/2074-2711-2017-3-10-17

Full Text:

Abstract

Perfusion computed tomography (PCT) is increasingly used to diagnose ischemic stroke (IS), as well as to identify candidates for thrombolytic therapy (TLT). The feasibility of using this technique in all patients within the therapeutic window has not yet been established.
Objective: to investigate cerebral blood flow according to PCT findings and its relationship to clinical and instrumental indicators and functional status of patients who had received TLT in the acute period of IS.
Patients and methods. 62 patients with acute IS who had received TLT were examined. All the patients underwent clinical, laboratory, and instrumental examinations and PCT, by assessing cerebral blood volume (CBV), cerebral blood flow (CBF), and mean transit time (MTT) in 10 brain regions in accordance with the Alberta Score Program Early CT Score (ASPECTS). The total result of perfusion ASPECTS was calculated separately for CBV, CBF and MTT, as well as combinations of these parameters. The penumbra size was calculated as CBV minus MTT (CBV - MTT) ASPECTS, the infarct core size was measured as CBV + MTT ASPECTS.
Results. There was an increase in MTT in most regions of interest of the affected hemisphere as compared to the intact one and a predominance of reversible perfusion disorders. The averaged penumbra size constituted three zones according to ASPECTS. No relationship was found between ASPECTS scores and time after the onset of symptoms prior to hospital admission. Perfusion parameters, particularly penumbra size (CBV - MTT), were associated with the degree of stenosis in the contralateral common carotid artery, body mass index, and blood triglyceride level. Cerebral blood flow indices were also influenced by red blood cell counts and heart ejection fraction. The scores of the perfusion scales were correlated with those of the non-contrast scale. The data of the investigated ASPECTS variants correlated with the level of neurological deficit in patients, its course, and the functional outcome of acute IS.
Conclusion. The perfusion variants of ASPECTS have a high predictive value for patients' neurologic and functional status upon completion of the first treatment stage. The penumbra size (CBV - MTT ASPECTS) is a marker for the expected regression of neurological impairment during TLT. The infarct core size (CBV + MTT ASPECTS) determines the degree of neurologic deficit at a patient's discharge.

About the Authors

A. A. Kulesh
Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia
Russian Federation
26, Petropavlovskaya St., Perm, Perm Territory 614990


V. E. Drobakha
Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia
Russian Federation
26, Petropavlovskaya St., Perm, Perm Territory 614990


N. A. Kaileva
Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia
Russian Federation
26, Petropavlovskaya St., Perm, Perm Territory 614990


L. I. Syromyatnikova
Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia
Russian Federation
26, Petropavlovskaya St., Perm, Perm Territory 614990


Yu. A. Golosova
Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia
Russian Federation
26, Petropavlovskaya St., Perm, Perm Territory 614990


V. V. Shestakov
Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia
Russian Federation
26, Petropavlovskaya St., Perm, Perm Territory 614990


References

1. Reiff T, Michel P. Reasons and evolution of non-thrombolysis in acute ischaemic stroke. Emerg Med J. 2017 Apr;34(4):219-226. doi: 10.1136/emermed-2015-205140. Epub 2016 Oct 25.

2. Шамалов НА. Реперфузионная терапия при ишемическом инсульте в Российской Федерации: проблемы и перспективы. Неврология, нейропсихиатрия, психосоматика. 2014;6(2S):15-22. [Shamalov NA. Reperfusion therapy for ischemic stroke in the Russian Federation: Problems and promises. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2014;6(2S):15-22. (In Russ.)]. doi: 10.14412/2074-2711-2014-2S-15-22

3. Bivard A, Levi C, Krishnamurthy V, et al. Perfusion computed tomography to assist decision making for stroke thrombolysis. Brain. 2015 Jul;138(Pt 7):1919-31. doi: 10.1093/brain/awv071. Epub 2015 Mar 25.

4. Шмырев ВИ, Морозов СП, Крыжановский МИ и др. Перфузионная компьютерная томография в диагностике цереброваскулярной патологии. Врач. 2011;(7):2-4. [Shmyrev VI, Morozov SP, Kryzhanovskii MI, et al. Perfusion computed tomography in the diagnosis of cerebrovascular disease. Vrach. 2011;(7):2-4. (In Russ.)].

5. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group—Alberta Stroke Programme Early CT Score. Lancet. 2000 May 13;355(9216):1670-4.

6. Coutts SB, Lev MH, Eliasziw M, et al. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke. 2004 Nov;35(11):2472-6. Epub 2004 Oct 14.

7. Aviv RI, Mandelcorn J, Chakraborty S, et al. Alberta Stroke Program Early CT Scoring of CT perfusion in early stroke visualization and assessment. AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1975-80. Epub 2007 Oct 5.

8. Schröder J, Thomalla G. A Critical Review of Alberta Stroke Program Early CT Score for Evaluation of Acute Stroke Imaging. Front Neurol. 2017 Jan 12;7:245. doi: 10.3389/fneur.2016.00245. eCollection 2016.

9. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients withacute ischaemic stroke selected by MRI perfusion-diffusionweighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2009 Feb;8(2):141-50. doi: 10.1016/S1474-4422(08)70267-9. Epub 2008 Dec 25.

10. Клинические рекомендации по проведению тромболитической терапии при ишемическом инсульте. [Clinical recommendations for thrombolytic therapy in ischemic stroke]. http://193.232.7.120/feml/clinical_ref/0001410674S/HTML

11. Donahue J, Wintermark M. Perfusion CT and acute stroke imaging: foundations, applications, and literature review. J Neuroradiol. 2015 Feb;42(1):21-9. doi: 10.1016/j.neurad.2014.11.003. Epub 2015 Jan 27.

12. Padroni M, Bernardoni A, Tamborino C, et al. Cerebral Blood Volume ASPECTS Is the Best Predictor of Clinical Outcome in Acute Ischemic Stroke: A Retrospective, Combined SemiQuantitative and Quantitative Assessment. LoS One. 2016 Jan 29;11(1):e0147910. doi: 10.1371/journal.pone.0147910. eCollection 2016.

13. Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke. 2007 Nov;38(11):2979-84. Epub 2007 Sep 27.

14. Kawano H, Bivard A, Lin L, et al. Perfusion computed tomography in patients with stroke thrombolysis. Brain. 2017 Mar 1;140(3):684-691. doi: 10.1093/brain/aww338.

15. Lum C, Ahmed ME, Patro S, et al. Computed tomographic angiography and cerebral blood volume can predict final infarct volume and outcome after recanalization. Stroke. 2014 Sep;45(9):2683-8. doi: 10.1161/STROKEAHA.114.006163. Epub 2014 Aug 7.

16. Zhu G, Michel P, Aghaebrahim A, et al. Prediction of recanalization trumps predictionof tissue fate: the penumbra: a dual-edged sword. Stroke. 2013 Apr;44 (4):1014-9. doi: 10.1161/STROKEAHA. 111.000229. Epub 2013 Mar 5.


Review

For citations:


Kulesh A.A., Drobakha V.E., Kaileva N.A., Syromyatnikova L.I., Golosova Yu.A., Shestakov V.V. Capabilities of perfusion ASPECTS in predicting the efficiency of intravenous thrombolytic therapy. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):10-17. https://doi.org/10.14412/2074-2711-2017-3-10-17

Views: 663


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)